BPC-157

Description

BPC-157

Other Known Titles: BPC-157, BPC 157, Body Protection Compound-157, Bepecin, PL-10, PLD-116, PL 14736
Peptide Type: Synthetic pentadecapeptide / gastric-derived peptide fragment
Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV)
Molecular Formula: C₆₂H₉₈N₁₆O₂₂
Molecular Weight: 1419.5 g/mol
CAS Number: 137525-51-0

BPC-157 is a synthetic 15-amino-acid peptide associated with the research history of a protective peptide fraction originally isolated from human gastric juice. It has become one of the more extensively investigated experimental peptides in studies of tissue repair, gastrointestinal integrity, vascular responses, and musculoskeletal recovery. PubChem identifies the peptide sequence as GEPPPGKPADDAGLV, with a molecular weight of approximately 1419.5 g/mol.

Gastrointestinal and Mucosal Research

One of the earliest areas of BPC-157 research concerns gastrointestinal protection. Experimental studies have examined the peptide in models involving gastric, intestinal, and other gastrointestinal injuries, with particular attention to preservation of mucosal integrity and restoration of damaged tissue. BPC-157 has also been described as unusually stable in gastric juice in experimental work, which helped establish its interest as a research candidate for gastrointestinal protection.

Research has investigated BPC-157 in models of ulceration and inflammatory bowel disease, including experimental work involving the upper and lower gastrointestinal tract. These studies have explored effects on tissue integrity, vascular responses, inflammatory processes, and wound repair rather than establishing a clinical treatment effect in humans.

Tendon and Ligament Research

BPC-157 has attracted substantial interest in musculoskeletal research because of findings in experimental tendon and ligament injury models. Studies have examined its influence on tendon fibroblast activity, cellular survival, migration, and tissue outgrowth. In a rat Achilles tendon injury model, BPC-157 was associated with changes in tendon healing and cellular responses relevant to repair.

This research has expanded into investigations of ligament, muscle, and bone injury. Reviews of the experimental literature describe recurring observations involving improved tissue organization, vascular responses, and repair-associated cellular activity across several types of musculoskeletal injury models.

Angiogenesis and Vascular Research

A major research theme surrounding BPC-157 is its interaction with vascular repair and angiogenesis. Experimental work has investigated the peptide’s effects on blood-vessel responses following tissue injury, including endothelial function, vascular stability, vessel formation, and restoration of circulation around damaged tissue.

Studies have connected these effects with signaling involving vascular endothelial growth factor (VEGF) and nitric oxide (NO). In animal models of muscle and tendon injury, BPC-157 has been associated with modulation of VEGF expression and angiogenic responses during healing. This has made vascular remodeling one of the principal mechanisms investigated in BPC-157 research.

More recent mechanistic research has proposed an additional pathway involving the FBXO22-BACH1 axis. Experimental findings reported that BPC-157 can interact with FBXO22 through its third proline residue, influencing BACH1 stability and endothelial-cell processes associated with vascular regeneration. This work provides a newer molecular framework for studying how the peptide may influence angiogenic responses.

Nitric Oxide and Endothelial Signaling

The nitric oxide system is another recurring subject in BPC-157 research. Experimental studies have investigated changes in NO-related signaling following vascular and tissue injury, including effects on endothelial function, vascular tone, and repair-associated responses. Rather than functioning simply as a conventional growth factor, BPC-157 has been studied for its ability to modulate several interconnected vascular pathways.

Research reviews have described interactions involving NO, VEGF, endothelial signaling, and pathways associated with vascular remodeling. These findings are particularly relevant to experimental models where restoration of blood supply and maintenance of vascular integrity are important components of tissue repair.

Wound-Healing and Tissue Repair Research

BPC-157 has been investigated in a broad range of experimental wound-healing models. Research has included injuries involving skin, muscle, tendon, ligament, bone, gastrointestinal tissue, and other organs. The repeated appearance of BPC-157 across these models has led researchers to investigate whether its effects arise from a broader cytoprotective or tissue-repair mechanism rather than a single tissue-specific action.

Recent reviews continue to describe experimental findings involving fibroblast activity, collagen-associated repair, angiogenesis, vascular integrity, oxidative-stress responses, and inflammatory signaling. These observations remain predominantly preclinical and should not be interpreted as proof of equivalent therapeutic effects in humans.

Cellular Protection and Stress Response

Another area of BPC-157 research involves cellular protection during physiological or pathological stress. Experimental literature has examined its effects on oxidative stress, mitochondrial integrity, inflammatory mediators, and cellular survival. These investigations have contributed to the broader concept of BPC-157 as a potentially pleiotropic experimental peptide with effects spanning multiple biological systems.

The peptide has also been investigated in experimental models involving neurological injury and dysfunction. Research has explored possible interactions with neurotransmitter systems, vascular regulation, and cellular stress responses, although these findings remain substantially less established than the peptide’s gastrointestinal and tissue-repair literature.

Inflammatory Research

BPC-157 has been studied in experimental models involving inflammatory injury, particularly within the gastrointestinal system and musculoskeletal tissues. Research has investigated its relationship with inflammatory signaling alongside tissue-repair processes, rather than treating inflammation as an isolated target.

This distinction is important because many BPC-157 studies examine inflammation, vascular remodeling, cellular migration, and tissue regeneration simultaneously. Consequently, the peptide is often described in the research literature as having pleiotropic activity, meaning that several biological pathways may contribute to the observed experimental effects.

Bone and Connective-Tissue Research

Beyond tendon and ligament models, BPC-157 has been evaluated in experimental studies of bone and connective-tissue repair. Researchers have investigated whether its vascular and cellular effects can support the complex repair environment required for regeneration of damaged connective tissues. Reviews have summarized findings across bone, tendon, ligament, and muscle models, with vascular and fibroblast-related mechanisms appearing repeatedly.

This area remains particularly relevant to regenerative-medicine research because successful connective-tissue recovery requires coordinated vascularization, cellular proliferation, extracellular-matrix remodeling, and restoration of tissue architecture.

Current Research and Translational Status

Despite extensive preclinical interest, BPC-157 remains an investigational peptide rather than an established FDA-approved therapeutic. PubChem records BPC-157 as having been investigated clinically, including the historical PCO-02 safety and pharmacokinetic study registered as NCT02637284; the ClinicalTrials.gov record has an unknown current status and does not provide publicly posted study results.

Current regulatory information also emphasizes the limitations of the human safety evidence. In 2026, the FDA reported that there was insufficient clinical safety information to characterize the safety profile of BPC-157 free base or BPC-157 acetate for proposed compounded uses, and noted limited information regarding several proposed routes of administration.

Accordingly, BPC-157 is best characterized as a research peptide with substantial preclinical literature but limited clinical validation. Its principal research areas include gastrointestinal protection, tissue repair, tendon and ligament biology, vascular remodeling, angiogenesis, nitric-oxide signaling, inflammatory responses, and cellular protection. Continued investigation is focused on clarifying its molecular mechanisms, pharmacokinetics, formulation characteristics, and potential translational applications.